Literature DB >> 11820304

Retinal vessel reaction to short-term IOP elevation in ocular hypertensive and glaucoma patients.

E Nagel1, W Vilser, I M Lanzl, I M Lanzi.   

Abstract

PURPOSE: Regulation of ocular blood flow might be impaired in glaucoma patients. We compared the reaction of retinal vessels to a short-term increase of intraocular pressure (IOP), using a retinal vessel analyzer (RVA), in normal volunteers, ocular hypertensive patients (OH) and primary open angle glaucoma patients (POAG).
METHODS: Ten healthy subjects (56+/-8 years, IOP 13.7+/-1.6 mmHg), 10 OH patients (55+/-12 years, IOD 23.4+/-4.1 mmHg) and 11 POAG patients (60+/-11 years, IOP 23.3+/-1.95 mmHg) were evaluated. Arterial and venous retinal vessel diameter was measured continuously before, during and after raising IOP to suprasystolic values by the suction cup method, described as ocular oscillo-dynamography.
RESULTS: The change in vessel diameter after the IOP rise differed in its temporal sequence and in absolute values depending on the group examined. In the retinal branch veins the reduction of vessel diameter during the IOP rise was significantly different in POAG (0%+/-6.7) and volunteers (-6.7%+/-8.5; p = 0.06) and in POAG and OH (-6.7%+/-7.0; p = 0.04). At 70-130 sec after IOP increase a dilatation occurred, again differing significantly in POAG (+5.8%+/-3.9) and volunteers (+9.7%+/-4.3; p = 0.03). Systemic blood pressure did not show any significant differences between groups or during the course of the examination. DISCUSSION: At short-term rise in IOP leads to less retinal vessel reaction in POAG patients than in volunteers and OH. This might be due to impaired autoregulation to ocular perfusion changes in POAG patients.

Entities:  

Mesh:

Year:  2001        PMID: 11820304

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  8 in total

1.  Static blood flow autoregulation in the optic nerve head in normal and experimental glaucoma.

Authors:  Lin Wang; Claude F Burgoyne; Grant Cull; Simon Thompson; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

2.  Retinal neurovascular coupling in patients with glaucoma and ocular hypertension and its association with the level of glaucomatous damage.

Authors:  K Gugleta; N Waldmann; A Polunina; A Kochkorov; R Katamay; J Flammer; S Orgul
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-19       Impact factor: 3.117

3.  Transient Visual Loss in Young Females with Crowded Optic Discs: A Proposed Aetiology.

Authors:  Stephen A Madill
Journal:  Neuroophthalmology       Date:  2021-06-18

4.  Longitudinal alterations in the dynamic autoregulation of optic nerve head blood flow revealed in experimental glaucoma.

Authors:  Lin Wang; Grant Cull; Claude F Burgoyne; Simon Thompson; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

5.  Prolonged retinal arteriovenous passage time is correlated to ocular perfusion pressure in normal tension glaucoma.

Authors:  Niklas Plange; Marion Kaup; Andreas Remky; Kay Oliver Arend
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-02       Impact factor: 3.117

6.  Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.

Authors:  M G Uva; A Longo; M Reibaldi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-27       Impact factor: 3.117

7.  Novel non-contact retina camera for the rat and its application to dynamic retinal vessel analysis.

Authors:  Dietmar Link; Clemens Strohmaier; Bernd U Seifert; Thomas Riemer; Herbert A Reitsamer; Jens Haueisen; Walthard Vilser
Journal:  Biomed Opt Express       Date:  2011-10-17       Impact factor: 3.732

8.  Does hemispheric vascular regulation differ significantly in glaucoma patients with altitudinal visual field asymmetry? A single-center, prospective study.

Authors:  David Kuerten; Konstantin Kotliar; Matthias Fuest; Peter Walter; Muriel Hollstein; Niklas Plange
Journal:  Int Ophthalmol       Date:  2021-05-19       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.